
Group Leader at @IRCM_MTP working on Epithelial Growth and Cancer
Montpellier, France
Joined November 2012
- Tweets575
- Following509
- Followers293
- Likes1.5K
Alexandre Djiane retweeted
The pipeline of emerging medicines for cancer cachexia.
By my count, there are 20 drugs in clinical trials, with 14 distinct mechanisms -- 9 of them focussed on the GDF15–GFRAL pathway, including two bispecifics (GDF15 × IL-6 and GDF15 × NGF).
There is even a vagus nerve-blocking device, that's now in phase 1!
Alexandre Djiane retweeted
New paper from the lab out in Cell Death & Disease @cddpress @CBM_CSIC_UAM "Transcription-dependent and -independent functions of Drosophila p53 isoforms in the induction of apoptosis and senescence-associated tumorigenesis.” #p53 #Drosophila Thread 1/9👇👇👇
Alexandre Djiane retweeted
What happens when tumor cells can't find enough nutrients? They "call" other cells. We have found a new mediator of this phenomenon: the multifunctional cytokine LIF 👇
Alexandre Djiane retweeted
Excited to share our last paper describing how intestinal stem cell migration promotes gut regeneration! @UCPH_Research @BIO_UCPH @NatureComms
nature.com/articles/s41467-0…
Alexandre Djiane retweeted
A ERC funded PhD offer at the iBV in Nice
ibv.unice.fr/job-offers/erc-…
Alexandre Djiane retweeted
Job offer at the iBV in Nice
ibv.unice.fr/job-offers/erc-…
Alexandre Djiane retweeted
Here it is! Free access. Nice figures (IMO). Enjoy!
febs.onlinelibrary.wiley.com…
Alexandre Djiane retweeted
Cancer Cachexia is unintentional weight loss caused by tumors. Education and awareness are critical for patients and caregivers, and to progress. The Cancer Support Community have created an excellent educational document on cachexia. Link in the comments.
Alexandre Djiane retweeted
Thrilled to present our study aiming to identify new vulnerabilities in lung cancer: biorxiv.org/content/10.1101/…
Joining forces from mouse genetics, thoracic oncology,
metabolism, and AlphaFold fields we dissected the role of a largely unknown but essential protein in cancer, FMO4 🧵
Alexandre Djiane retweeted
I'm excited to share this review on using #Drosophila as a model for human rare diseases! I cover the fundamentals of disease modeling and offer my perspective on the current state of the field.@SEBiolDev @SaludISCIII @PNBB_ISCIII @drosospain @CajalFlyHub
mdpi.com/2075-4450/15/11/870
Alexandre Djiane retweeted
Montpellier is such a vibrant place to live, and the @IRCM_MTP is one of the leading cancer institute in France- highly recommended! Bonus points for the amazing climate (both scientific and weather!)- junior people, go for it!
This Post is from an account that no longer exists. Learn more
Alexandre Djiane retweeted
Great days at the #35thDrosoFrance Meeting—inspiring science, conviviality, and plenty of oysters! See you all in Rennes in 2026!
Alexandre Djiane retweeted
3-year funded post-doctoral position to study oocyte development using a combination of cutting-edge approaches in cell biology and biophysics. If you are interested and want to know more about the project, please send a CV and contact me.
Alexandre Djiane retweeted
🚀 @GustaveRoussy déploie, à l'échelle nationale, le profilage génomique par biopsie liquide pour les patients atteints de #cancer.
Lire le communiqué de presse ⤵ gustaveroussy.fr/fr/gustave-…
Alexandre Djiane retweeted
Our review on a topic we eagerly enjoy exploring in the lab- how our fav immune cell types influence/are influenced by metabolic disorders preceding cancer- so much to learn! 👏🏻👏🏻 to #DanielTaranto for leading the effort, to @djkloosterman and the whole lab for their input! 🔥🔥
NEW content online! Macrophages and T cells in metabolic disorder-associated cancers go.nature.com/4duhbCv
Alexandre Djiane retweeted
Interested in understanding how regeneration is controlled during development and adulthood? Keen to develop your skills in genetics, advanced imaging and 'omics? Join us for a PhD @theCrick! 🔬
crick.ac.uk/careers-study/va…
Alexandre Djiane retweeted
Proud and gratefull to share our last study on liposarcoma that that has just been published in @naturecoms
We show the link between muscle and liposarcoma. Targeting IL-6💊disrupts serine metabolism, slowing tumor growth and survival. Promising new therapies ahead!💪
Alexandre Djiane retweeted
🚨New publication🚨from @LaetitiaLinares Lab at @Inserm in @NatureComms
👉 rdcu.be/dTLkl
We've discovered a metabolic link between muscle and liposarcoma. Targeting IL-6💊disrupts serine metabolism, slowing tumor growth and survival. Promising new therapies ahead!💪
Alexandre Djiane retweeted
Latest from Bruno Hudry and lab, featuring tools to visualise endogenous TraF expression and genetically interrogate it nature.com/articles/s41467-0…


























